March 20, 2022
A leading drug for tuberculosis (TB) that has begun to lose its potency due to antibiotic resistance can be used to combat the infection through more than one pathway, according to new research by Weill Cornell Medicine and NewYork-Presbyterian scientists. The findings suggest a new path for developing better, safer cures for TB. ... Read More